SGS S.A.. (11/2/16). "Press Release: Dr. Katrien Lemmens Appointed Medical Director for Early Phase Clinical Trials".

	Region	Antwerpen
	Country	Belgium
	Organisation	SGS Clinical Research
	Group	SGS (Group)
	Organisation 2	University of Antwerp
	Product	clinical research services
	Product 2	pharmacology
	Person	Lemmens, Katrien (SGS 201611– Medical Director Early Phase Clinical Trials at SGS Clinical Research)
	Person 2	Marsat, Jean-Luc (SGS 201611 Managing Director at SGS Clinical Research)

SGS, a leading life sciences pharmaceutical clinical and bioanalytical contract solutions provider, today announced the appointment of Dr. Katrien Lemmens as Medical Director for early phase clinical trials.

Dr. Lemmens joins the medical team based at its 88-bed clinical pharmacology unit in Antwerp, Belgium. In total, the SGS clinical pharmacology unit in Antwerp now employs nine full time medical doctors: four clinical research physicians, four investigators and one safety physician.

Dr. Lemmens obtained her MD in 2000, and a PhD in 2006 from the University of Antwerp. She started her medical career as a clinical cardiologist, before undertaking a post-doctoral position at the physio-pharmacology laboratories at the University of Antwerp. Dr. Lemmens went on to join Janssen Pharmaceuticals where she was Medical Director of its Clinical Pharmacology Unit in Meksem, before rejoining the University of Antwerp as Associate Professor of Pathophysiology and Pharmacology.

“Katrien joins SGS at an exciting time for the company. We look to strengthen our medical team with talents to match our strategy of ensuring our clients have access to best in class experts and services for their early phase patient clinical trials,” commented Jean-Luc Marsat, Managing Director at SGS Clinical Research. “Understanding the increasingly complex clinical needs of clients and implementing solutions is what drives us as a company. This year we have seen the appointment of five senior medical staff to our team to increase and diversify the expertise we can offer.”

SGS provides Phase I to IV clinical trial management and services, encompassing data management and statistics, PK/PD modelling and simulation, pharmacovigilance and regulatory consultancy. In addition to its clinical research services, SGS leverages its wholly-owned global network, with 21 laboratories offering contract analytical and bioanalytical services. These laboratories are present in North America, Europe, and Asia, and deliver harmonized solutions to large pharmaceutical and biotechnology firms.

For further information, please contact:

Florent Hediard
Life Sciences – Marketing Director
Agriculture, Food and Life
SGS, 29 av A. Briand, 94111 Arcueil, France
t: +33 (0) 1 41 24 84 95

Richard Kerns
President
NEPR
t: +44 (0)161 728 5880

About SGS

SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 85,000 employees, SGS operates a network of over 1,800 offices and laboratories around the world.

Record changed: 2021-01-05